Study targets EGFR and FGFR cellular pathways to treat rare diseaseContinue reading
Category Archives: AZBio News
NCI SBIR Direct to Phase II Pilot Program
Direct to Phase II Pilot Program is here!
Jump Into New Funding Opportunities Now
Finding funding to continue your innovative cancer research can be difficult. Luckily, there’s some good news.
The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center is implementing the SBIR Direct to Phase II Pilot solicitation, PAR-14-088, per the 2011 SBIR & STTR Reauthorization Act, allowing applicants that have demonstrated the R&D and technical merit characteristic of a Phase I (R43) SBIR project to bypass Phase I and apply directly for SBIR Phase II grants.
We encourage you to review the opportunity below and consider applying.
|
|
|
How to Apply
For resources and examples of SBIR grant applications and contract proposals, please visit http://sbir.cancer.gov/resource/apply/.
Please visit http://sbir.cancer.gov/ to learn more about the NCI SBIR & STTR Programs.
The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.
Sign up to receive updates about
SBIR & STTR funding opportunities at
sbir.cancer.gov
Teens Get an Early Taste of Health Professions at Summer Program
Applications Now Being Taken for High Schoolers to Attend UA College of Medicine – Phoenix’s Med-Start ProgramContinue reading
Leaders from AZBio Member Companies Named “Most Influential”
Eight Leaders from AZBio Member Companies were named the most influential people in biopharma today by Fierce Biotech.Continue reading
HTG Molecular Diagnostics Completes Initial Series E Preferred Stock Offering
TUCSON, AZ, Feb 11, 2014 (Media Release) — HTG Molecular Diagnostics (“HTG”) today announced the initial closing of its Series E offering with existing investors Novo Ventures, SROne, Merck Capital Ventures, and Fletcher Spaght. Proceeds will support commercial and product development initiatives.Continue reading
TGen study uncovers possible genetic markers in breast cancer that spreads to the brain
New treatments might be possible for patients who now have little hopeContinue reading
Help Inspire A Generation: Tell them why you love what you do
This Valentine’s Week… take a minute to share what you do and why you love it.Continue reading
10th Annual Edson Student Entrepreneur Initiative Launches
Innovation Group PLC : Arizona State University Launches Startup Competition to Find Next Generation of Student EntrepreneursContinue reading
Mathematical Model Developed by UA Physicists Could Help Treat Lyme Disease
A computer simulation of Lyme disease rash might help doctors better predict the spread of the bacteria in the early stages when antibiotics are most effective.
By University Communications, February 6, 2014Continue reading
NuvOx Makes the Transition from the Laboratory to the Clinic and is Pounding the Pavement to Raise $15MM.
NuvOx Pharma, a Tucson-based biotech startup, founded in 2008 is metamorphosing from an R&D startup to one that is testing the Company’s nanotechnology therapeutic platform in the clinic.Continue reading